InsiderClue
← All stocks

Olema Pharmaceuticals, Inc.

OLMA Net selling
CIK 0001750284 #2588 in the set updated 20 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$24.74M
$0.00 on a plan · $19.18M straight out of an exercise
Sold at will
$5.56M
11 of 25 sales
Net
−$24.74M
−$5.56M against sales at will

By person

12 insiders · 26 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
CLARK IAN T
Director
—
$7.87M (3) scheduled
−$7.87M
0
0.0000%
$0.00
—
Zojwalla Naseem
CHIEF MEDICAL OFFICER
—
$7.53M (4) scheduled
−$7.53M
4,488
0.0051%
$52.57K
−95.3%
Myles David C.
CH. DISCOV. & NON-CLIN DEV OFF
—
$4.66M (8) scheduled
−$4.66M
687,607
0.7859%
$8.05M
−6.4%
Kovacs Shane William Charles
CH. OPERATING & FINANCIAL OFF.
—
$2.98M (2)
−$2.98M
139,727
0.1597%
$1.64M
−71.2%
Mitchell Shawnte
CHIEF LEGAL OFFICER
—
$951.50K (3) scheduled
−$951.50K
0
0.0000%
$0.00
—
Harmon Cyrus
Director
—
$743.76K (5)
−$743.76K
819,798
0.9369%
$9.60M
−6.1%
Bain Capital Life Sciences Investors, LLC entity
10% owner
—
—
—
4,300,000
4.91%
$50.37M
−42.7%
Graham G. Walmsley
Director
—
—
—
1,408,875
1.61%
$16.50M
−49.9%
BVF PARTNERS L P/IL entity
Director
—
—
—
347,970
0.3977%
$4.08M
−91.6%
Bohen Sean
PRESIDENT AND CEO
—
—
—
237,650
0.2716%
$2.78M
+57.5%
Austin Sasha Lu
VP of Finance and Controller
—
—
—
16,188
0.0185%
$189.63K
+260.7%
RAPPAPORT ANDREW
Director
—
—
—
0
0.0000%
$0.00
—

Individual transactions

11
Insider
Date
Role
Action
Shares
Price
Amount
Harmon Cyrus
24 Jul 2026
Director
Sell
12,500
$11.71
$146.43K
Harmon Cyrus
23 Jul 2026
Director
Sell
12,500
$11.58
$144.74K
Harmon Cyrus
20 Jan 2026
Director
Sell
10,000
$26.88
$268.80K
Kovacs Shane William Charles
15 Jan 2026
CH. OPERATING & FINANCIAL OFF.
Sell
100,000
$28.73
$2.87M
Harmon Cyrus
14 Jan 2026
Director
Sell
3,489
$29.12
$101.60K
Kovacs Shane William Charles
13 Jan 2026
CH. OPERATING & FINANCIAL OFF.
Sell
3,822
$28.01
$107.05K
Myles David C.
12 Jan 2026
CH. DISCOV. & NON-CLIN DEV OFF
Sell indirect
10,000
$28.34
$283.40K
Harmon Cyrus
22 Dec 2025
Director
Sell
2,881
$28.53
$82.19K
Myles David C.
19 Dec 2025
CH. DISCOV. & NON-CLIN DEV OFF
Sell
6,046
$31.39
$189.78K
Myles David C.
19 Dec 2025
CH. DISCOV. & NON-CLIN DEV OFF
Sell
43,729
$30.40
$1.33M
Myles David C.
19 Dec 2025
CH. DISCOV. & NON-CLIN DEV OFF
Sell
1,225
$28.08
$34.40K
Show all 26 transactions →

What was left out

Form 4 filings counted 32
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 14
Sales at will 11
Transactions with no price 0
Shares from compensation/vesting 945,736
History held since 19 Nov 2020